Advertisement

Fertilitätserhalt in der Onkologie

  • Ralf DittrichEmail author
  • Laura Lotz
  • Michael von Wolff
Chapter
Part of the Springer Reference Medizin book series (SRM)

Zusammenfassung

Fertilitätsprotektive Maßnahmen spielen aufgrund steigender Überlebensraten bei Krebserkrankungen sowie Fortschritten in der Reproduktionsmedizin zunehmend eine Rolle. Bei Männern ist die Kryokonservierung von Spermien allgemein etabliert. Im Falle einer Azoospermie sollte die testikuläre Spermienextraktion angeboten werden. Bei Frauen bestehen die Möglichkeit der Verwendung von GnRH-Agonisten zur Reduktion der ovariellen Schädigung, die Kryokonservierung von Oozyten und Ovargewebe und die ovarielle Transposition. Bei der Fülle von Möglichkeiten zum Fertilitätserhalt muss oft ein multimodales Konzept individuell mit der Patientin besprochen werden. Viele der Methoden sind gut kombinierbar. Eine zügige und zeitparallele Zusammenarbeit mit einem spezialisierten Zentrum, insbesondere jenen des Netzwerks FertiPROTEKT e. V., und die korrekte ausführliche Beratung der betroffenen Frauen und Männer sind dabei unerlässlich.

Literatur

  1. Albers P et al (2015) Guidelines on testicular cancer: 2015 update. Eur Urol 68:1054–1068.  https://doi.org/10.1016/j.eururo.2015.07.044CrossRefPubMedGoogle Scholar
  2. Alvarez RM, Ramanathan P (2016) Fertility preservation in female oncology patients: the influence of the type of cancer on ovarian stimulation response. Hum Reprod.  https://doi.org/10.1093/humrep/dew158
  3. Anderson RA et al (2013) Induction of puberty by autograft of cryopreserved ovarian tissue in a patient previously treated for Ewing sarcoma. Eur J Cancer 49:2960–2961.  https://doi.org/10.1016/j.ejca.2013.04.031CrossRefPubMedGoogle Scholar
  4. Balduzzi A et al (2017) Fertility preservation issues in pediatric hematopoietic stem cell transplantation: practical approaches from the consensus of the Pediatric Diseases Working Party of the EBMT and the International BFM Study Group. Bone Marrow Transplant 52(10):1406–1415.  https://doi.org/10.1038/bmt.2017.147CrossRefPubMedGoogle Scholar
  5. Barahmeh S et al (2013) Ovarian transposition before pelvic irradiation: indications and functional outcome. J Obstet Gynaecol Res 39:1533–1537.  https://doi.org/10.1111/jog.12096CrossRefPubMedGoogle Scholar
  6. Bastings L et al (2013) Autotransplantation of cryopreserved ovarian tissue in cancer survivors and the risk of reintroducing malignancy: a systematic review. Hum Reprod Update 19:483–506.  https://doi.org/10.1093/humupd/dmt020CrossRefPubMedGoogle Scholar
  7. Baysal O et al (2015) Decision-making in female fertility preservation is balancing the expected burden of fertility preservation treatment and the wish to conceive. Hum Reprod 30:1625–1634.  https://doi.org/10.1093/humrep/dev116CrossRefPubMedGoogle Scholar
  8. Bedaiwy MA et al (2011) Gonadotropin-releasing hormone analog cotreatment for preservation of ovarian function during gonadotoxic chemotherapy: a systematic review and meta-analysis. Fertil Steril 95:906–914. e901-904.  https://doi.org/10.1016/j.fertnstert.2010.11.017CrossRefPubMedGoogle Scholar
  9. Borgmann-Staudt A et al (2015) AMWF S1-Leitlinie (025/034) Beeinträchtigung der Gonadenfunktion nach Chemo- und Strahlentherapie im Kindes- und Jugendalter: Risiken, Diagnostik, Prophylaxe- und Behandlungsmöglichkeiten. http://www.awmf.org/uploads/tx_szleitlinien/025-034_l_S1_Beeinträchtigung_Gonadenfunktion_nach_Krebs_im_Kindesalter_2015-03.pdf. Zugegriffen am 14.12.2015
  10. Chen H et al (2011) Adjuvant gonadotropin-releasing hormone analogues for the prevention of chemotherapy induced premature ovarian failure in premenopausal women. Cochrane Database Syst Rev (3):CD008018.  https://doi.org/10.1002/14651858.CD008018.pub2
  11. Colpi GM et al (2009) Microsurgical TESE versus conventional TESE for ICSI in non-obstructive azoospermia: a randomized controlled study. Reprod Biomed Online 18:315–319CrossRefGoogle Scholar
  12. Daudin M et al (2015) Sperm cryopreservation in adolescents and young adults with cancer: results of the French national sperm banking network (CECOS). Fertil Steril 103:478–486.e471.  https://doi.org/10.1016/j.fertnstert.2014.11.012CrossRefGoogle Scholar
  13. Del Mastro L et al (2014) Gonadotropin-releasing hormone analogues for the prevention of chemotherapy-induced premature ovarian failure in cancer women: systematic review and meta-analysis of randomized trials. Cancer Treat Rev 40:675–683.  https://doi.org/10.1016/j.ctrv.2013.12.001CrossRefPubMedGoogle Scholar
  14. Demeestere I et al (2015) Live birth after autograft of ovarian tissue cryopreserved during childhood. Hum Reprod 30:2107–2109.  https://doi.org/10.1093/humrep/dev128CrossRefPubMedGoogle Scholar
  15. Demeestere I et al (2016) No evidence for the benefit of gonadotropin-releasing hormone agonist in preserving ovarian function and fertility in lymphoma survivors treated with chemotherapy: final long-term report of a prospective randomized trial. J Clin Oncol Off J Am Soc Clin Oncol 34:2568–2574.  https://doi.org/10.1200/jco.2015.65.8864CrossRefGoogle Scholar
  16. Dittrich R et al (2010) Fertility preservation in cancer patients. Minerva Ginecol 62:63–80PubMedGoogle Scholar
  17. Dittrich R et al (2012) Live birth after ovarian tissue autotransplantation following overnight transportation before cryopreservation. Fertil Steril 97:387–390.  https://doi.org/10.1016/j.fertnstert.2011.11.047CrossRefPubMedGoogle Scholar
  18. Dittrich R et al (2013) Oncofertility: combination of ovarian stimulation with subsequent ovarian tissue extraction on the day of oocyte retrieval. Reprod Biol Endocrinol 11:19CrossRefGoogle Scholar
  19. Dolmans MM et al (2013) Risk of transferring malignant cells with transplanted frozen-thawed ovarian tissue. Fertil Steril 99:1514–1522.  https://doi.org/10.1016/j.fertnstert.2013.03.027CrossRefPubMedGoogle Scholar
  20. Donnez J et al (2013) Restoration of ovarian activity and pregnancy after transplantation of cryopreserved ovarian tissue: a review of 60 cases of reimplantation. Fertil Steril 99:1503–1513.  https://doi.org/10.1016/j.fertnstert.2013.03.030CrossRefPubMedGoogle Scholar
  21. Hovav Y et al (2001) Electroejaculation before chemotherapy in adolescents and young men with cancer. Fertil Steril 75:811–813CrossRefGoogle Scholar
  22. Huober Zeeb C et al (2011) Improving fertility preservation in cancer: ovarian tissue cryobanking followed by ovarian stimulation can be efficiently combined. Fertil Steril 95(1):342–344.  https://doi.org/10.1016/j.fertnstert.2010.07.1074CrossRefPubMedGoogle Scholar
  23. Hwang JH et al (2012) Association between the location of transposed ovary and ovarian function in patients with uterine cervical cancer treated with (postoperative or primary) pelvic radiotherapy. Fertil Steril 97:1387–1393. e1381-1382.  https://doi.org/10.1016/j.fertnstert.2012.02.052CrossRefPubMedGoogle Scholar
  24. Jahnukainen K et al (2011) Testicular function and fertility preservation in male cancer patients. Best Pract Res Clin Endocrinol Metab 25:287–302.  https://doi.org/10.1016/j.beem.2010.09.007CrossRefPubMedGoogle Scholar
  25. Jahnukainen K et al (2012) Autologous ectopic grafting of cryopreserved testicular tissue preserves the fertility of prepubescent monkeys that receive sterilizing cytotoxic therapy. Cancer Res 72:5174–5178.  https://doi.org/10.1158/0008-5472.can-12-1317CrossRefPubMedPubMedCentralGoogle Scholar
  26. Kamischke A et al (2004) Cryopreservation of sperm from adolescents and adults with malignancies. J Androl 25:586–592CrossRefGoogle Scholar
  27. Kicinski M et al (2015) Publication bias in meta-analyses from the Cochrane Database of Systematic Reviews. Stat Med 34:2781–2793.  https://doi.org/10.1002/sim.6525CrossRefPubMedGoogle Scholar
  28. Kim J et al (2016) Long-term safety of letrozole and gonadotropin stimulation for fertility preservation in women with breast cancer. J Clin Endocrinol Metab 101:1364–1371.  https://doi.org/10.1210/jc.2015-3878CrossRefPubMedPubMedCentralGoogle Scholar
  29. Kliesch S et al (1996) Cryopreservation of semen from adolescent patients with malignancies. Med Pediatr Oncol 26:20–27CrossRefGoogle Scholar
  30. Kliesch S et al (2009) Kryokonservierung menschlicher Spermien zur Zeugungsreserve. In: Nieschlag E, Behre HM, Nieschlag S (Hrsg) Andrologie: Grundlagen und Klinik der reproduktiven Gesundheit des Mannes. Springer, Berlin/Heidelberg, S 515–531CrossRefGoogle Scholar
  31. Kurt M et al (2007) Successful spontaneous pregnancy in a patient with rectal carcinoma treated with pelvic radiotherapy and concurrent chemotherapy: the unique role of laparoscopic lateral ovary transposition. Eur J Gynaecol Oncol 28:408–410PubMedGoogle Scholar
  32. Lambertini M et al (2016) Cancer and fertility preservation: international recommendations from an expert meeting. BMC Med 14:1.  https://doi.org/10.1186/s12916-015-0545-7CrossRefPubMedPubMedCentralGoogle Scholar
  33. Lawrenz B et al (2010) Efficacy and safety of ovarian stimulation before chemotherapy in 205 cases. Fertil Steril 94:2871–2873.  https://doi.org/10.1016/j.fertnstert.2010.06.054CrossRefPubMedGoogle Scholar
  34. Lambertini M et al (2018) Gonadotropin-Releasing Hormone Agonists During Chemotherapy for Preservation of Ovarian Function and Fertility in Premenopausal Patients With Early Breast Cancer: A systematic review and meta-analysis of individual Patient-Level data. J Clin Oncol 36:1981–1990CrossRefGoogle Scholar
  35. Lee SJ et al (2006) American Society of Clinical Oncology recommendations on fertility preservation in cancer patients. J Clin Oncol Off J Am Soc Clin Oncol 24:2917–2931.  https://doi.org/10.1200/jco.2006.06.5888CrossRefGoogle Scholar
  36. Liebenthron J et al (2013) The impact of culture conditions on early follicle recruitment and growth from human ovarian cortex biopsies in vitro. Fertil Steril 100:483–491.e485.  https://doi.org/10.1016/j.fertnstert.2013.03.046CrossRefPubMedGoogle Scholar
  37. Lotz L et al (2011) Xenotransplantation of cryopreserved ovarian tissue from patients with ovarian tumors into SCID mice – no evidence of malignant cell contamination. Fertil Steril 95:2612–2614.e2611.  https://doi.org/10.1016/j.fertnstert.2011.05.003CrossRefPubMedGoogle Scholar
  38. Magelssen H et al (2005) Twenty years experience with semen cryopreservation in testicular cancer patients: who needs it? Eur Urol 48:779–785.  https://doi.org/10.1016/j.eururo.2005.05.002CrossRefPubMedGoogle Scholar
  39. Marconi M et al (2012) Combined trifocal and microsurgical testicular sperm extraction is the best technique for testicular sperm retrieval in „low-chance“ nonobstructive azoospermia. Eur Urol 62:713–719.  https://doi.org/10.1016/j.eururo.2012.03.004CrossRefPubMedGoogle Scholar
  40. Meistrich ML et al (1997) Rapid recovery of spermatogenesis after mitoxantrone, vincristine, vinblastine, and prednisone chemotherapy for Hodgkin’s disease. J Clin Oncol 15:3488–3495CrossRefGoogle Scholar
  41. Meistrich ML et al (2013) Effects of chemotherapy and radiotherapy on spermatogenesis in humans. Fertil Steril 100:1180–1186.  https://doi.org/10.1016/j.fertnstert.2013.08.010CrossRefPubMedGoogle Scholar
  42. Moore HC et al (2015) Goserelin for ovarian protection during breast-cancer adjuvant chemotherapy. N Engl J Med 372:923–932.  https://doi.org/10.1056/NEJMoa1413204CrossRefPubMedPubMedCentralGoogle Scholar
  43. Mossa B et al (2015) Ovarian transposition in young women and fertility sparing. Eur Rev Med Pharmacol Sci 19:3418–3425PubMedGoogle Scholar
  44. Muller J, Skakkebaek NE (1983) Quantification of germ cells and seminiferous tubules by stereological examination of testicles from 50 boys who suffered from sudden death. Int J Androl 6:143–156CrossRefGoogle Scholar
  45. Munhoz RR et al (2015) Gonadotropin-releasing hormone agonists for ovarian function preservation in premenopausal women undergoing chemotherapy for early-stage breast cancer: a systematic review and meta-analysis. JAMA Oncol:1–9.  https://doi.org/10.1001/jamaoncol.2015.3251CrossRefGoogle Scholar
  46. Pedersen JL et al (1993) Spermaturia and puberty. Arch Dis Child 69:384–387CrossRefGoogle Scholar
  47. Poirot C et al (2012) Induction of puberty by autograft of cryopreserved ovarian tissue. Lancet 379:588.  https://doi.org/10.1016/s0140-6736(11)61781-9CrossRefPubMedGoogle Scholar
  48. Rosendahl M et al (2011) Cryopreservation of ovarian tissue for a decade in Denmark: a view of the technique. Reprod Biomed Online 22:162–171.  https://doi.org/10.1016/j.rbmo.2010.10.015CrossRefPubMedGoogle Scholar
  49. Rosendahl M et al (2013) The safety of transplanting cryopreserved ovarian tissue in cancer patients: a review of the literature. J Assist Reprod Genet 30:11–24.  https://doi.org/10.1007/s10815-012-9912-xCrossRefPubMedGoogle Scholar
  50. S2k-Leitlinie (2017) Fertilitätsehalt bei onkologischen Erkrankungen (AWMF Register-No. 015/082). http://www.awmf.org/leitlinien/detail/ll/015-082.html
  51. Salih SM et al (2015) Diminished utilization of in vitro fertilization following ovarian transposition in cervical cancer patients. J Reprod Med 60:345–353PubMedPubMedCentralGoogle Scholar
  52. Schlatt S et al (2009) Testicular stem cells for fertility preservation: preclinical studies on male germ cell transplantation and testicular grafting. Pediatr Blood Cancer 53:274–280.  https://doi.org/10.1002/pbc.22002CrossRefPubMedGoogle Scholar
  53. Schover LR (2005) Motivation for parenthood after cancer: a review. J Natl Cancer Inst Monogr:2–5.  https://doi.org/10.1093/jncimonographs/lgi010CrossRefGoogle Scholar
  54. Schüring A et al (2017) Practical recommendations for fertility preservation in women by the FertiPROTEKT network. Part I: indications for fertility preservation. Arch Gynecol Obstet 24.  https://doi.org/10.1007/s00404-017-4594-3CrossRefGoogle Scholar
  55. Shetty G, Meistrich ML (2005) Hormonal approaches to preservation and restoration of male fertility after cancer treatment. J Natl Cancer Inst Monogr: 36–39.  https://doi.org/10.1093/jncimonographs/lgi002CrossRefGoogle Scholar
  56. Stukenborg JB et al (2009) New horizons for in vitro spermatogenesis? An update on novel three-dimensional culture systems as tools for meiotic and post-meiotic differentiation of testicular germ cells. Mol Hum Reprod 15:521–529.  https://doi.org/10.1093/molehr/gap052CrossRefPubMedGoogle Scholar
  57. Teh WT et al (2014) The impact of uterine radiation on subsequent fertility and pregnancy outcomes. Biomed Res Int 2014:482968.  https://doi.org/10.1155/2014/482968CrossRefPubMedPubMedCentralGoogle Scholar
  58. Telfer EE, McLaughlin M (2011) In vitro development of ovarian follicles. Semin Reprod Med 29:15–23.  https://doi.org/10.1055/s-0030-1268700CrossRefPubMedGoogle Scholar
  59. Tournaye H et al (2014) Fertility preservation in men with cancer. Lancet 384:1295–1301.  https://doi.org/10.1016/s0140-6736(14)60495-5CrossRefGoogle Scholar
  60. Van der Ven H et al (2016) Ninety-five orthotopic transplantations in 74 women of ovarian tissue after cytotoxic treatment in a fertility preservation network: tissue activity, pregnancy and delivery rates. Hum Reprod 31:2031–2041.  https://doi.org/10.1093/humrep/dew165CrossRefPubMedGoogle Scholar
  61. Wallace WH et al (2003) The radiosensitivity of the human oocyte. Hum Reprod 18:117–121CrossRefGoogle Scholar
  62. Wallace WH et al (2005) Predicting age of ovarian failure after radiation to a field that includes the ovaries. Int J Radiat Oncol Biol Phys 62:738–744.  https://doi.org/10.1016/j.ijrobp.2004.11.038CrossRefPubMedGoogle Scholar
  63. Wang C et al (2013) Gonadotropin-releasing hormone analog cotreatment for the preservation of ovarian function during gonadotoxic chemotherapy for breast cancer: a meta-analysis. PLoS One 8:e66360.  https://doi.org/10.1371/journal.pone.0066360CrossRefPubMedPubMedCentralGoogle Scholar
  64. Wolff M et al von (2009) Ovarian stimulation to cryopreserve fertilized oocytes in cancer patients can be started in the luteal phase Fertil Steril 92:1360–1365  https://doi.org/10.1016/j.fertnstert.2008.08.011CrossRefGoogle Scholar
  65. Wolff M et al von (2011a) Combination of gonadotropin-releasing hormone (GnRH) agonists with GnRH antagonists before chemotherapy reduce but does not completely prevent a follicle-stimulating hormone flare-up Fertil Steril 95:452–454  https://doi.org/10.1016/j.fertnstert.2010.08.053CrossRefGoogle Scholar
  66. Wolff M et al von (2011b) Fertility preservation in women – a practical guide to preservation techniques and therapeutic strategies in breast cancer, Hodgkin’s lymphoma and borderline ovarian tumours by the fertility preservation network FertiPROTEKT Arch Gynecol Obstet 284:427–435  https://doi.org/10.1007/s00404-011-1874-1CrossRefGoogle Scholar
  67. Wolff M et al von (2016) Timing of ovarian stimulation in patients prior to gonadotoxic therapy: an analysis of 684 stimulations Eur J Obstet Gynecol Reprod Biol 199:146–149  https://doi.org/10.1016/j.ejogrb.2016.02.006CrossRefGoogle Scholar
  68. Wolff M et al von (2017) Practical recommendations for fertility preservation in women by the FertiPROTEKT network. Part II: fertility preservation techniques Arch Gynecol Obstet 27.  https://doi.org/10.1007/s00404-017-4595-2CrossRefGoogle Scholar
  69. Yang B et al (2013) Concurrent treatment with gonadotropin-releasing hormone agonists for chemotherapy-induced ovarian damage in premenopausal women with breast cancer: a meta-analysis of randomized controlled trials. Breast 22:150–157.  https://doi.org/10.1016/j.breast.2012.12.008CrossRefPubMedGoogle Scholar
  70. Zhang Y et al (2013) Gonadotropin-releasing hormone for preservation of ovarian function during chemotherapy in lymphoma patients of reproductive age: a summary based on 434 patients. PLoS One 8:e80444.  https://doi.org/10.1371/journal.pone.0080444CrossRefPubMedPubMedCentralGoogle Scholar

Copyright information

© Springer-Verlag GmbH Deutschland, ein Teil von Springer Nature 2020

Authors and Affiliations

  1. 1.FrauenklinikUniversitätsklinikum Erlangen, Friedrich Alexander Universität Erlangen-NürnbergErlangenDeutschland
  2. 2.Frauenklinik des Universitätsklinikums ErlangenFriedrich-Alexander Universität Erlangen-NürnbergErlangenDeutschland
  3. 3.Universitätsklinik für Frauenheilkund, Abteilung für Gynäkologische Endokrinologie und ReproduktionsmedizinInselspital, Universitätsklinikum BernBernSchweiz

Personalised recommendations